Lenisna

The product is designed as a time-acting filler with 170 mg of PDLLA , and 30 mg of uncross-linked hyaluronic acid.

Lenisna is a hybrid filler which have connected both benefits of immediate filling efect of HA (hyaluronic acid) and long-term stimulation of collagen production by PDLLA (Poly D,L – lactide).

Lenisna Indications:
Due to the high concentration of poly D,L lactic acid – 170 mg and hyaluronic acid – 30 mg, the treatment is intended for people:

with clear signs of aging 40 +
needing to increase the volume of sunken areas of the face
especially for the correction of skin depressions such as: folds in the skin, wrinkles, and furrows, as well as in the case of face drooping and skin laxity

Lenisna Effects:

The effects of the therapy are visible immediately after administration. We obtain a filling effect thanks to the presence of hyaluronic acid. After about 2 weeks, the production of collagen is initiated by the presence of PDLLA lactic acid microparticles. The effects of the therapy last for over two years after the last treatment. The recommended number of treatments is 2 or 3, depending on the skin deficiency, at intervals of 6-8 weeks. After two years it is recommended to carry out 1 reminder treatment.

Method:
the preparation in the amount of 5 ml is administered with the use of a thin cannula of 22 to 25 G size or needles of 25-26 G size
it is applied to the subcutaneous or periosteal tissue
Ingredients:

170 mg PDLLA
30 mg HA
This pack consists of:

1 Vial: 5 ml

CE certified